Chairman Michael J. Farrell - 08 Sep 2026 Form 4/A - Amendment Insider Report for RESMED INC (RMD)

Reporting relationship: Chairman and CEO, Director
Issuer ticker: RMD
Reported as of: 08 Sep 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 01 Oct 2026, 16:29:28 UTC
Original report date: 10 Sep 2026
Prior SEC filing: 01 Oct 2026
Next SEC filing: 02 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ Lisa Beyer, attorney-in-fact for Mr. Farrell

Key filing fact

Chairman Michael J. Farrell filed Form 4/A - Amendment for RESMED INC (RMD) on 01 Oct 2026.

Key facts

This page summarizes Chairman Michael J. Farrell's Form 4/A - Amendment filing for RESMED INC (RMD).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 01 Oct 2026, 16:29.

Change

Previous filing in this sequence was filed on 01 Oct 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001485164 Primary reporting owner

Farrell Michael J.

Relationship: Chairman and CEO, Director
Address: RESMED INC., 9001 SPECTRUM CENTER BLVD, SAN DIEGO
Signature: /s/ Lisa Beyer, attorney-in-fact for Mr. Farrell
Signature date: 01 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD holding

ResMed Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 479,803
Date: 08 Sep 2026
Ownership: Direct
Footnotes: F1

RMD holding

ResMed Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,090
Date: 08 Sep 2026
Ownership: Lisette and Michael Farrell Family Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This amendment is being filed solely to update the number of shares beneficially owned by the Reporting Person following the transaction reported on the original Form 4 filed on September 10, 2026. The transaction reported on the original Form 4 is unchanged.